More importantly, in ApcMin/KRAS V12 double transgenic mice that had a great tendency to develop small intestine tumors, deleting one allele of Klf5 led to a 92% reduction in tumor burden [34]. The gene discussed is KLF5; the disease is small intestine neoplasm.